New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.
Doctors and aging experts say early intervention is key. When dementia is diagnosed early on, there are more treatment and ...
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
Dr. Linda Girgis discusses how physicians can assist caregivers of patients with dementia, helping these critical caretakers ...
18h
Hosted on MSNNight-time dementia warning sign appears in your sleep 'decades' before other symptomsA new study has found that a warning sign of dementia may appear in your sleep, with nightmares becoming more prevalent years ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...
It’s a slow and painful goodbye for patients and loved ones — but some are determined to fight back. At the University of ...
When people think about cognitive decline, they often imagine the obvious symptoms: forgetfulness, confusion, or difficulty ...
Adults in their 70s with dementia experienced faster weight loss in the decade before diagnosis than their cognitively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results